Previous Close | 4.98 |
1-Year Change | -69.69% |
6-Months Change | -41.69% |
3-Months Change | -10.43% |
Moving Avg (50d) | 4.2532 |
Moving Avg (200d) | 6.753 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 180.2M |
Beta (3-Years) | 1.64 |
Revenue Growth (ttm) | 6.97% |
Net Profit Margin (ttm) | -24.22% |
Return On Assets (ttm) | -18.24% |
EPS (ttm) | -2.87 |
PE Ratio (ttm) | -1.74 |
Dividend Yield | % |
Asset Description: | Nevro Corp. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2025-01-15 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
4.88 | 4.731 | 4.631 | 4.482 | 4.233 | 3.984 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.